Meridian Bioscience Reports Second Quarter 2017 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2017 Guidance
Go back to Meridian Bioscience Reports Second Quarter 2017 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2017 Guidance| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 5.87 +0.42 (7.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.45 | 52 Week High | $21.49 | |||
| Open | $5.51 | 52 Week Low | $15.75 | |||
| Day High | $6.24 | P/E | 6.67 | |||
| Day Low | $5.35 | EPS | $0.88 | |||
| Volume | 1,863,790 | |||||
